Genetics and pain

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 22, Issue 3, 2008, Pages 232-235

  Persson, Elise ^a   Rhodin, Annica ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gene therapy; Genetics; Pain; Single nucleotide polymorphisms; SNPs

Indexed keywords

DNA POLYMORPHISM; GENE EXPRESSION; GENE MUTATION; GENE THERAPY; GENETIC SUSCEPTIBILITY; HUMAN; NOTE; PAIN; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; ARTICLE; GENE EXPRESSION REGULATION; GENETICS; METHODOLOGY;

ANIMALS; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; HUMANS; PAIN; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 60249088767     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.1080/15360280802251272     Document Type: Note

References (16)

1. Mogli J ed. The genetics of pain (progress in pain research and management v28). IASP Press, 2004.
2. Belfer I, Wu T, Kingman A et al. Candidate gene studies of human pain mechanisms: methods for optimizing choice ofpolymorphisms and sample size. Anesthesiology. 2004;100:1562-1572.
3. Diatchenko L, Slade GD, Nackley AG et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet. 2005;14:135-143.
4. Bond C, LaForge KS, Tian M et al. Singlenucleotide polymorphisminthe humanmuopioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci. 1998;95:9608-9613.
5. Janicki PK, Schuler G, Francis D et al. A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain. Anesth Analg. 2006;103:1011-1017.
6. Klepstad P, Rakvag TT, Kaasa S et al. The 118 A > G polymorphism in the human mu- opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesth Scand. 2004;48:1232-1239.
7. Fillingim RB, KaplanL,StaudRetal. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain. 2005;6:159-167.
8. Zubieta JK, Heitzeg MM, Smith YR et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science. 2003;299:1240-1203.
9. Gürsoy S, Erdal E, Herken H et al. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int. 2003;23:104-107.
10. Estevez M, Gardner KL. Update on the genetics of migraine. Hum Genet. 2004;114:225-235.
11. Yu-Qing C. Voltage-gated calcium channels and pain. Pain. 2006;126:5-9.
12. Bessler H, Shavit Y, Mayburd E et al. Postoperative pain, morphine consumption, and genetic polymorphism of IL-1beta and IL-1 receptor antagonist. Neurosci Lett. 2006;404:154-158.
13. Noponen-Hietala N, Virtanen I, Karttunen R et al. Genetic variations in IL6 associate with intervertebral disc disease characterized by sciatica. Pain. 2005;114:186-194.
14. Shoskes DA, AlbakriQ,Thomas K et al. Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response. J Urol. 2002;168:331-335.
15. Bueller JA, Aftab M, Sen S et al. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry. 2006;59:812-815.
16. Tegeder I, Costigan M, Griffin RS et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med. 2006;12: 1269-1277.